Infectious Diseases
August 15, 2022
ROCHESTER, Minn. — Mayo Clinic researchers say the monoclonal antibody bebtelovimab, already authorized by the Food and Drug Administration for emergency use on the omicron[...]
March 9, 2016
March 8, 2016
March 8, 2016
March 7, 2016
March 2, 2016
February 23, 2016
February 22, 2016
February 22, 2016
February 17, 2016
February 16, 2016
February 10, 2016
Explore more topics
Sign up
Mayo Clinic Connect
An online patient support community